PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148946
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148946
The global compression therapy market size was valued at USD 4.58 billion in 2025 and is projected to reach USD 4.89 billion in 2026 and USD 8.15 billion by 2034. The market is supported by the increasing prevalence of venous and lymphatic disorders, a growing geriatric population, rising awareness of compression-based treatment, and continuous product innovation. North America dominated the compression therapy market with a 34.77% share in 2025, supported by advanced healthcare infrastructure, high healthcare expenditure, strong research activities, and increasing prevalence of lymphedema and venous leg ulcers.
Market Definition and Scope
Compression therapy is a clinically established treatment approach that applies controlled pressure to the limbs to improve venous blood circulation and support lymphatic drainage. It is widely used for managing lymphedema, venous leg ulcers, deep vein thrombosis, chronic venous insufficiency, and other vascular conditions. Products include compression garments, compression pumps, and other specialized systems. Growing adoption across hospitals, clinics, nursing care centers, and home-care settings is expanding the market. Technological improvements are also creating more comfortable, effective, and patient-friendly compression solutions.
Market Dynamics
Drivers - Increasing Prevalence of Venous and Lymphatic Disorders
The rising incidence of lymphedema, venous leg ulcers, varicose veins, and deep vein thrombosis is a major factor supporting market growth. Immobility, obesity, pregnancy, previous thrombosis, surgeries, and chronic venous insufficiency can increase the risk of these conditions. Growing awareness of compression garments and pneumatic compression devices is encouraging healthcare professionals and patients to adopt these treatment options.
Trends - Growing Adoption of Advanced Compression Garments
Compression garments are increasingly being used as an effective option for managing chronic venous and lymphatic disorders. Manufacturers are introducing advanced garments and multi-component compression systems designed to improve pressure distribution, comfort, and treatment effectiveness. Increasing product development and clinical research are further supporting adoption.
Restraints - High Cost and Limited Awareness
The high cost of compression pumps and limited awareness of compression therapy in developing countries remain important challenges. Patients and healthcare providers in emerging markets may have restricted access to advanced products because of affordability, inadequate healthcare infrastructure, and limited knowledge about available treatment options.
Impact of COVID-19
The COVID-19 pandemic disrupted healthcare services, elective treatments, product manufacturing, and distribution networks. Reduced hospital visits and delays in non-emergency procedures affected demand for certain compression therapy products. However, the increased focus on home-based healthcare and remote patient management created opportunities for products suitable for independent use. Healthcare providers also placed greater emphasis on treatment approaches that could reduce unnecessary hospital visits, supporting long-term interest in home-care compression solutions.
By Product
The market is segmented into compression garments, compression pumps, and others. Compression garments dominated the market and accounted for 71.8% of the market in 2025, supported by their broad use in venous and lymphatic disease management. Compression pumps are expected to experience strong growth due to increasing adoption for lymphedema treatment and continued product launches.
By Application
Applications include venous leg ulcer, DVT, lymphedema, and others. Lymphedema represents a major application area because of the increasing patient population and growing use of compression pumps and garments. Venous leg ulcers also contribute significantly due to their prevalence among elderly patients and individuals with chronic venous conditions.
By End User
The market includes hospitals & clinics, nursing care centers, home care, and others. Hospitals & clinics are expected to maintain a leading position because of skilled healthcare professionals, advanced treatment facilities, product availability, and favorable reimbursement conditions. Home care is gaining momentum as the geriatric population increases and patients seek convenient treatment options.
North America
North America led the market, with a regional market value of USD 1.05 billion in the reported regional analysis. High R&D investment, product launches, developed healthcare infrastructure, and the prevalence of lymphedema and venous diseases support regional demand.
Europe
Europe is expected to maintain its position as a significant market, supported by new product launches, established healthcare systems, and increasing awareness of compression-based treatment. Growing demand for advanced solutions is encouraging manufacturers to strengthen their presence across European countries.
Asia Pacific
Asia Pacific is projected to register the fastest growth, supported by an expanding geriatric population, increasing disposable income, improving healthcare infrastructure, and a growing patient pool suffering from chronic venous and lymphatic disorders. Japan is expected to reach USD 246.0 million by 2025.
Latin America and Middle East & Africa
Latin America and the Middle East & Africa are expected to experience moderate expansion as healthcare infrastructure improves and advanced compression products become more accessible. Increasing unmet medical needs and growing awareness are supporting opportunities across these regions.
Competitive Landscape
Key companies operating in the compression therapy market include SIGVARIS, 3M, Arjo, PAUL HARTMANN Pty. Ltd., medi GmbH & Co. KG, Essity Aktiebolag, Smith & Nephew, Bio Compression Systems, Inc., and Tactile Systems Technology, Inc. Companies are focusing on new product development, distribution expansion, strategic partnerships, acquisitions, and portfolio diversification to strengthen their market positions.
Key Industry Developments
Koya Medical received FDA clearance for its compression therapy system designed for the lower extremities. DeRoyal entered a USD 1.2 million agreement with Tyndall and RCSI SWaT researchers to advance compression wound therapy. AIROS Medical introduced updated compression therapy products, including the AIROS 6 Sequential Compression Therapy device and Arm Plus garments. Theragun acquired RP Sports and its RecoveryPump clinical pneumatic compression technology product line.
Report Coverage
The compression therapy market report provides qualitative and quantitative insights into market size, market value, segmentation, regional analysis, competitive dynamics, product developments, and emerging opportunities. It evaluates compression garments, compression pumps, applications, and end-user categories while examining regional market conditions and major industry developments. The report also covers product innovation, strategic partnerships, mergers and acquisitions, regulatory developments, healthcare infrastructure, and changing treatment preferences.
Conclusion
The compression therapy market is positioned for continued growth as the prevalence of venous and lymphatic disorders increases and healthcare providers adopt advanced compression-based treatment solutions. The global market is projected to increase from USD 4.58 billion in 2025 to USD 4.89 billion in 2026 and USD 8.15 billion by 2034. Compression garments will remain a key product category, while compression pumps and home-care solutions are expected to create additional opportunities. Rising geriatric populations, improved healthcare infrastructure, product innovation, and greater awareness of effective vascular and lymphatic disease management will remain important factors shaping the market.
Unit Value (USD billion)
Segmentation By Product
By Application
By End User
By Geography